Labcorp
738 hedge funds and large institutions have $14.9B invested in Labcorp in 2019 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 268 increasing their positions, 263 reducing their positions, and 54 closing their positions.
262% more call options, than puts
Call options by funds: $86.6M | Put options by funds: $23.9M
6% more funds holding in top 10
Funds holding in top 10: 16 → 17 (+1)
2% more repeat investments, than reductions
Existing positions increased: 268 | Existing positions reduced: 263
0.21% more ownership
Funds ownership: 105.91% → 106.12% (+0.21%)
0% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 54
0% less funds holding
Funds holding: 741 → 738 (-3)
3% less capital invested
Capital invested by funds: $15.4B → $14.9B (-$509M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Melvin Capital Management
New York
|
+$212M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$182M |
| 3 |
HM
HealthCor Management
New York
|
+$80.4M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$45.9M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$36.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$134M |
| 2 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$85.3M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$84.8M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$72.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$57.6M |
LH Hedge Fund Activity: Q3 2019 in Review
738 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q3 2019, worth a combined $14.9B — down 3.3% from $15.4B a quarter earlier.
Fund positioning in LH was balanced in Q3 2019: 54 funds opened new positions, 54 closed out, 268 added to existing stakes and 263 trimmed.
The largest buyer was Melvin Capital Management, adding an estimated $212M. The largest seller was Boston Partners, cutting an estimated $134M.
- 738 institutional investors held Labcorp (LH) as of Q3 2019, down from 741 in Q2 2019.
- Funds reported $14.9B of Labcorp stock for Q3 2019, down 3.3% quarter-over-quarter.
- 54 funds opened new Labcorp positions in Q3 2019 and 54 closed out, a net change of 0 holders.
- The largest Labcorp buyer in Q3 2019 was Melvin Capital Management, an estimated $212M added.
- The largest Labcorp seller in Q3 2019 was Boston Partners, an estimated $134M sold.
Based on aggregated 13F filings for Q3 2019.